论文部分内容阅读
目的比较钼靶和超声对乳腺癌的诊断价值。方法回顾2014年9月至2016年3月我院收治并经手术证实的乳腺癌患者46例,术前均行钼靶和超声检查,诊断报告采用BI-RADS分类系统,以4、5类为阳性统计恶性征象的检出率和准确诊断率。结果术后病理包括浸润型导管癌26例、浸润型小叶癌5例、原位癌6例、腺癌8例,混合癌1例;钼靶检出恶性形态29例(63.0%)、微钙化19例(40.8%),准确诊断38例(82.6%);超声检出恶性形态30例(65.2%),微钙化10例(21.1%),RI≥0.7有31例(67.4%),准确诊断40例(87.1%);钼靶和超声对恶性形态检出率的差异无统计学意义(χ~2=0.05,P>0.05),对微钙化和异常血流检出率的差异有统计学意义(χ~2=4.18,P<0.05;χ~2=46.76,P<0.05),准确诊断率的差异无统计学意义(χ~2=0.36,P>0.05)。结论钼靶和超声优势互补,应作为乳腺癌筛查的“黄金组合”在临床上推广。
Objective To compare the diagnostic value of mammography and ultrasound in breast cancer. Methods From September 2014 to March 2016,46 cases of breast cancer who were admitted to our hospital and confirmed by surgery were performed preoperatively with mammography and ultrasonography. The diagnostic report was based on the BI-RADS classification system. Positive statistical malignant signs of the detection rate and accurate diagnosis rate. Results There were 26 cases of infiltrating ductal carcinoma, 5 cases of invasive lobular carcinoma, 6 cases of carcinoma in situ, 8 cases of adenocarcinoma and 1 case of mixed carcinoma. The malignant morphology of molybdenum target detected in 29 cases (63.0%), microcalcification Thirty-nine cases (40.8%) were correctly diagnosed, 38 cases (82.6%) were correctly diagnosed, 30 cases (65.2%) were diagnosed malignantly by ultrasound, 10 (21.1%) were microcalcifications, 31 40 cases (87.1%). There was no significant difference in the detection rate of malignant morphology between mammography and ultrasound (χ ~ 2 = 0.05, P> 0.05). There was a statistically significant difference in the detection rates of microcalcification and abnormal blood flow (Χ ~ 2 = 4.18, P <0.05; χ ~ 2 = 46.76, P <0.05). There was no significant difference in the accuracy of diagnosis (χ ~ 2 = 0.36, P> 0.05). Conclusion The advantages of mammography and ultrasound complement each other should be screened for breast cancer “golden combination ” in the clinical promotion.